BTK and atrial fibrillation: A daily dose of selleckchem (ibrutinib), a non-specific Bruton tyrosine kinase inhibitor intraperitoneally injected for 4 weeks in mice, produced spontaneous AF, left atrial enlargement, myocardial fibrosis, and increased inflammation accompanied by prolonged atrial effective refractory periods without profound alteration in the action potential duration [49].